YMR1 Antibody

What is YMR1 and why is it significant for scientific research?

YMR1 is a yeast myotubularin-related phosphatase that functions as a phosphoinositide 3-phosphatase in vivo, specifically dephosphorylating PI(3)P at the D3 position of the inositol ring . It plays a crucial role in PI(3)P-dependent signaling pathways and maintains endosomal system integrity . YMR1 is significant for research for several reasons:

• It is the only myotubularin homolog in Saccharomyces cerevisiae, making it a simplified model for studying myotubularin function

• YMR1 deletion yields fragmented vacuoles (yeast lysosomes) and approximately doubles intracellular PI(3)P levels

• It shares functional overlap with synaptojanin-like phosphatases (Sjl2/Inp52 and Sjl3/Inp53), with the triple deletion being lethal, indicating essential roles in phosphoinositide regulation

• YMR1 provides insights into human myotubularin functions, which are linked to severe genetic disorders when mutated

How does YMR1 function differ from other phosphoinositide phosphatases in yeast?

YMR1 exhibits distinct substrate specificity and functional characteristics compared to other yeast phosphoinositide phosphatases:

What are optimal methodologies for detecting YMR1 expression in experimental samples?

Several complementary techniques can be employed to effectively detect YMR1 expression:

• Western blotting: Using specific anti-YMR1 antibodies allows direct quantification of protein levels. For optimal results:

  • Include ymr1Δ knockout samples as negative controls to verify antibody specificity

  • Use both wild-type and YMR1 overexpression samples to calibrate signal intensity

  • Add a loading control (e.g., actin or GAPDH) to normalize expression levels

• Immunofluorescence microscopy:

  • Use paraformaldehyde fixation to preserve protein localization

  • Permeabilize with 0.1% Triton X-100 for optimal antibody access

  • Include DAPI nuclear staining for cellular orientation

  • Compare patterns with subcellular markers (e.g., vacuolar or endosomal markers)

• YMR1-GFP fusion protein analysis:

  • Express YMR1-GFP under native promoter to avoid artifacts from overexpression

  • Validate functionality by confirming the fusion protein complements ymr1Δ phenotypes

  • Use live-cell imaging to track dynamic localization patterns

• qRT-PCR:

  • Design primers spanning exon junctions to avoid genomic DNA amplification

  • Include reference genes for normalization (e.g., ACT1, TDH3)

  • Validate primer efficiency using standard curves

Combining these approaches provides comprehensive characterization of YMR1 expression at both protein and mRNA levels.

How should researchers design experiments to study YMR1's role in phosphoinositide regulation?

To effectively investigate YMR1's role in phosphoinositide regulation, researchers should implement a multi-faceted experimental approach:

• Genetic manipulation strategies:

  • Generate ymr1Δ single knockout strains using homologous recombination

  • Create double mutants (ymr1Δsjl2Δ or ymr1Δsjl3Δ) to assess functional redundancy

  • Develop temperature-sensitive YMR1 alleles for conditional studies (as demonstrated with ts mutants in search result )

  • Use controlled expression systems (e.g., GAL1 promoter) for inducible YMR1 expression

• Phosphoinositide level measurement:

  • Implement HPLC analysis of radiolabeled phosphoinositides for quantitative assessment

  • Utilize specific PI(3)P biosensors (e.g., 2xFYVE-GFP) for in vivo visualization

  • Employ mass spectrometry-based lipidomics to profile multiple phosphoinositide species simultaneously

• Functional assays:

  • Analyze vacuolar morphology using FM4-64 staining to detect fragmentation phenotypes

  • Assess endosomal trafficking using cargo trafficking assays

  • Examine growth characteristics under various stress conditions

• Rescue experiments:

  • Express wild-type YMR1 in mutant backgrounds to confirm phenotype specificity

  • Test catalytically inactive mutants (e.g., active site cysteine to serine mutations as mentioned in )

  • Evaluate cross-species complementation with human myotubularins to assess functional conservation

• In vitro phosphatase assays:

  • Express and purify recombinant YMR1 for enzymatic characterization

  • Test substrate specificity using synthetic phosphoinositide substrates

  • Analyze enzyme kinetics to determine catalytic efficiency

This comprehensive approach will provide robust insights into YMR1's role in phosphoinositide regulation.

What controls are essential when conducting immunoprecipitation with YMR1 antibodies?

When performing immunoprecipitation (IP) experiments with YMR1 antibodies, the following controls are essential to ensure reliability and specificity:

• Genetic validation controls:

  • Wild-type sample (positive control): Cell lysate containing endogenous YMR1

  • ymr1Δ knockout sample (negative control): Confirms antibody specificity and identifies non-specific bands

  • YMR1 overexpression sample: Enhances signal detection and confirms band identity

• Antibody controls:

  • Isotype control IP: Use matched isotype antibody to identify non-specific binding

  • No-antibody control: Assesses non-specific binding to beads alone

  • Pre-immune serum control (for polyclonal antibodies): Establishes baseline background

• Technical controls:

  • Input sample (5-10% of lysate): Confirms protein presence before IP

  • Unbound fraction: Assesses IP efficiency

  • Pre-clearing step: Reduces non-specific binding to beads

• Validation controls:

  • Reciprocal IP of interaction partners: Confirms interactions bidirectionally

  • Competition with recombinant YMR1: Validates antibody specificity

  • Sequential IP: For more stringent validation of protein complexes

• Sensitivity controls:

  • Titration of antibody amounts: Determines optimal antibody:protein ratio

  • Varying wash stringency: Balances between maintaining genuine interactions and eliminating background

These controls collectively ensure that observations from YMR1 immunoprecipitation experiments are reliable and biologically relevant.

How can researchers optimize detection of YMR1 using immunofluorescence microscopy?

Optimizing YMR1 detection using immunofluorescence microscopy requires careful attention to several methodological aspects:

• Fixation and permeabilization optimization:

  • Compare multiple fixation methods (e.g., 4% paraformaldehyde, methanol, or glutaraldehyde)

  • Test different permeabilization agents (Triton X-100, saponin, digitonin) at varying concentrations

  • Optimize fixation time to balance epitope preservation and cellular architecture

• Antibody selection and validation:

  • Test multiple antibodies targeting different YMR1 epitopes

  • Validate antibody specificity using ymr1Δ cells as negative controls

  • Determine optimal antibody concentration through titration experiments

  • Compare different secondary antibodies for signal-to-noise optimization

• Signal enhancement strategies:

  • Implement tyramide signal amplification for low-abundance detection

  • Use high-sensitivity detection systems (e.g., quantum dots or highly cross-adsorbed fluorophores)

  • Apply antigen retrieval techniques if epitopes are masked

• Co-localization studies:

  • Include markers for relevant compartments (endosomes, vacuoles)

  • Use spectrally distinct fluorophores to minimize bleed-through

  • Implement pixel-by-pixel colocalization analysis

• Advanced imaging techniques:

  • Apply deconvolution algorithms to enhance resolution

  • Consider super-resolution microscopy (STED, STORM, or SIM) for detailed localization

  • Use time-lapse imaging with YMR1-GFP to complement fixed-cell analysis

• Quantitative analysis:

  • Develop consistent thresholding protocols

  • Measure signal intensity relative to validated markers

  • Perform automated image analysis for unbiased quantification

These optimizations will enhance detection sensitivity and specificity while providing meaningful biological information about YMR1 localization and function.

How can researchers effectively study the functional relationship between YMR1 and synaptojanin-like phosphatases?

To elucidate the functional relationship between YMR1 and synaptojanin-like phosphatases (Sjl2/Inp52 and Sjl3/Inp53), researchers should implement the following advanced approaches:

• Genetic interaction analysis:

  • Generate a comprehensive set of single, double, and conditional triple mutants (ymr1Δ, sjl2Δ, sjl3Δ, ymr1Δsjl2Δ, ymr1Δsjl3Δ, sjl2Δsjl3Δ, and conditional ymr1Δsjl2Δsjl3Δ)

  • Perform quantitative growth assays under various conditions to assess synthetic fitness defects

  • Implement high-throughput genetic interaction mapping using systematic gene deletion libraries

• Rescue and cross-complementation:

  • Test whether overexpression of each phosphatase can rescue phenotypes of other phosphatase mutants

  • Create phosphatase chimeras combining domains from YMR1 and synaptojanin-like phosphatases

  • Employ dosage-sensitive genetic interactions by varying expression levels of each phosphatase

• Comprehensive phosphoinositide profiling:

  • Implement mass spectrometry-based lipidomics to quantify multiple phosphoinositide species (PI(3)P, PI(4)P, PI(5)P, PI(3,5)P₂)

  • Combine with subcellular fractionation to determine compartment-specific phosphoinositide changes

  • Develop live-cell sensors for simultaneous monitoring of multiple phosphoinositide species

• Synthetic rescue analysis:

  • Test whether a targeted PI(3)P-specific chimeric phosphatase (e.g., GFP-Sac1ΔC-FYVE EEA1 described in ) can rescue mutant phenotypes

  • Identify the minimal functional domains required for complementation

  • Determine whether direct manipulation of phosphoinositide levels can bypass phosphatase requirements

• Proteomic approaches:

  • Perform comparative interactome analysis of YMR1 versus Sjl proteins

  • Implement proximity labeling (BioID or APEX) to identify compartment-specific interaction partners

  • Conduct temporal proteomics following acute inactivation of each phosphatase

This integrative approach will reveal the extent of functional overlap, specificity, and cooperativity between YMR1 and synaptojanin-like phosphatases in phosphoinositide regulation.

What techniques can detect changes in YMR1 subcellular localization during cellular stress?

Detecting stress-induced changes in YMR1 localization requires sophisticated imaging and biochemical approaches:

• Live-cell imaging techniques:

  • Express YMR1-GFP under native promoter control for physiological expression levels

  • Implement spinning disk confocal microscopy for rapid time-lapse acquisition with minimal phototoxicity

  • Use additional fluorescent markers for key compartments (endosomes, vacuoles, Golgi)

  • Apply microfluidic systems for precise control of stress application timing and intensity

• Stress-specific experimental protocols:

  • Osmotic stress: Apply hyperosmotic shock (0.4M NaCl) and monitor immediate relocalization

  • Nutrient deprivation: Track YMR1 during nitrogen or carbon source starvation

  • Oxidative stress: Apply H₂O₂ treatment and assess localization changes

  • pH stress: Monitor YMR1 during intracellular or extracellular pH perturbations

• Advanced imaging analysis:

  • Implement automated image segmentation for organelle-specific quantification

  • Apply single-particle tracking to follow individual YMR1-containing structures

  • Use ratiometric imaging to normalize against volume changes during stress

• Biochemical fractionation approaches:

  • Perform subcellular fractionation before and after stress application

  • Quantify YMR1 distribution across fractions by immunoblotting

  • Combine with phosphoproteomics to correlate localization with phosphorylation state

• Proximity-based detection:

  • Apply split-fluorescent protein systems to detect stress-induced protein-protein interactions

  • Use FRET-based biosensors to detect conformational changes upon stress

  • Implement BioID or APEX proximity labeling to identify stress-specific interaction partners

These approaches will provide comprehensive insights into how cellular stress modulates YMR1 localization and function.

How can researchers develop assays to measure YMR1 phosphatase activity in various experimental contexts?

Developing robust assays for YMR1 phosphatase activity requires consideration of both in vitro biochemical approaches and cellular functional readouts:

• In vitro enzymatic assays:

  • Recombinant protein preparation: Express and purify full-length YMR1 or catalytic domain using bacterial or yeast expression systems

  • Malachite green phosphate detection: Measure inorganic phosphate release from synthetic phosphoinositide substrates

  • Fluorogenic substrate assays: Use fluorogenic substrates like DiFMUP that increase fluorescence upon dephosphorylation

  • HPLC-based substrate depletion assays: Quantify conversion of PI(3)P to PI using chromatographic separation

• Cell-based activity assays:

  • PI(3)P biosensor systems: Express fluorescently tagged PI(3)P-binding domains (e.g., 2xFYVE-GFP) to monitor PI(3)P levels and localization in living cells

  • Flow cytometry applications: Develop high-throughput flow cytometry assays using PI(3)P-specific fluorescent probes

  • Phenotypic readouts: Quantify vacuolar morphology as a functional endpoint of YMR1 activity

• Structure-function analysis tools:

  • Mutational analysis: Generate point mutations in catalytic residues (as done with C392S in ) to create enzymatically inactive controls

  • Domain swapping: Create chimeric proteins with domains from related phosphatases to assess substrate specificity determinants

  • Chemical genetics: Engineer analog-sensitive YMR1 variants for selective inhibition

• Temporal control strategies:

  • Inducible expression systems: Use GAL1 or TET-off/on promoters for controlled expression timing

  • Anchor-away approaches: Rapidly relocalize YMR1 from functional sites using rapamycin-induced dimerization

  • Temperature-sensitive alleles: Generate conditional YMR1 alleles for acute inactivation

• Substrate specificity profiling:

  • Lipidomic analysis: Compare phosphoinositide profiles in wild-type versus ymr1Δ cells using mass spectrometry

  • In vitro substrate panel: Test activity against multiple phosphoinositide species to determine specificity

  • Competition assays: Use competitive inhibitors to assess substrate preferences

These diverse approaches will provide comprehensive insights into YMR1 phosphatase activity across different experimental contexts.

How should researchers interpret contradictory results between different YMR1 detection methods?

When facing contradictory results between different YMR1 detection methods, researchers should systematically evaluate potential technical and biological factors:

• Method-specific considerations:

  • Antibody-based detection: Assess antibody specificity using ymr1Δ controls; epitope accessibility may vary across cellular compartments or experimental conditions

  • YMR1-GFP fusion: Evaluate whether the GFP tag (27 kDa) affects localization, function, or stability; confirm functionality through complementation testing

  • mRNA quantification: Remember that mRNA levels may not correlate with protein abundance due to post-transcriptional regulation

• Technical optimization approach:

  • Compare multiple fixation methods for immunofluorescence (paraformaldehyde, methanol, glutaraldehyde)

  • Test both N-terminal and C-terminal tagged versions of YMR1-GFP

  • Validate with subcellular fractionation followed by immunoblotting

  • Use orthogonal methods like proximity labeling to confirm localization

• Expression level considerations:

  • Native expression: Use endogenous promoter-driven expression to avoid artifacts

  • Overexpression effects: High-copy plasmids (e.g., pRS425 mentioned in ) may cause mislocalization

  • Inducible systems: Titrate expression levels to identify threshold effects

• Dynamic behavior analysis:

  • Time-course studies: YMR1 localization may change over time or cell cycle stages

  • Stress-induced changes: Different methods may capture YMR1 in different states

  • Cell-to-cell variability: Consider single-cell analysis to detect heterogeneous responses

• Resolution considerations:

  • Diffuse versus punctate localization: Different methods may have different sensitivities to detection patterns

  • Membrane association dynamics: Consider membrane fractionation to detect transient associations

  • Co-localization quantification: Apply rigorous statistical analysis of co-localization data

What are common pitfalls in analyzing phosphoinositide profiles in YMR1 mutant strains?

Analysis of phosphoinositide profiles in YMR1 mutant strains presents several challenges that researchers should anticipate and address:

• Technical limitations:

  • Extraction efficiency variability: Phosphoinositides have different extraction efficiencies based on their head group and localization

  • Detection sensitivity issues: Minor phosphoinositide species may fall below detection limits

  • Normalization challenges: Cellular phospholipid content can vary between strains and conditions

  • Rapid turnover: Phosphoinositides have fast metabolism that can be affected by sample processing

• Biological complexity factors:

  • Compensatory mechanisms: Other phosphatases (Sjl2/Inp52 and Sjl3/Inp53) may compensate for YMR1 loss, as indicated by the synthetic lethality of the triple deletion

  • Spatial redistribution: Total phosphoinositide levels may remain unchanged while subcellular distribution changes dramatically

  • Metabolic interconversion: Changes in one phosphoinositide species can affect levels of others through metabolic pathways

  • Growth phase dependency: Phosphoinositide profiles change significantly with growth phase and nutrient availability

• Experimental design considerations:

  • Control standardization: Ensure wild-type and mutant strains are harvested at identical growth phases

  • Internal standards: Use synthetic phosphoinositide standards for accurate quantification

  • Sample processing speed: Minimize time between cell harvesting and lipid extraction

  • Technical replicates: Include multiple biological and technical replicates to account for variability

• Advanced analytical approaches:

  • Subcellular fractionation: Analyze phosphoinositides in specific organelle fractions

  • In vivo sensors: Complement bulk measurements with fluorescent biosensor imaging

  • Enzyme inhibitors: Use specific inhibitors to block phosphoinositide metabolism during extraction

  • Acute inactivation: Employ temperature-sensitive alleles or chemical genetics for time-resolved analysis

By addressing these pitfalls, researchers can obtain more accurate and biologically meaningful phosphoinositide profiles from YMR1 mutant studies.

How can researchers differentiate between direct and indirect effects of YMR1 deletion?

Distinguishing direct from indirect effects of YMR1 deletion requires careful experimental design and multiple complementary approaches:

• Temporal analysis strategies:

  • Acute inactivation: Use temperature-sensitive YMR1 alleles (as mentioned in ) or chemical-genetic approaches to observe immediate effects

  • Time-course studies: Monitor phenotypes at multiple time points after YMR1 inactivation

  • Inducible expression: Use regulatable promoters to acutely restore YMR1 function and identify rapidly reversed phenotypes

• Structure-function approaches:

  • Catalytic mutants: Compare phenotypes between catalytically inactive YMR1 (e.g., C392S mutation mentioned in ) and complete deletion

  • Domain deletion analysis: Assess the contribution of different YMR1 domains to specific phenotypes

  • Separation-of-function mutants: Identify mutations that affect some but not all YMR1 functions

• Substrate manipulation:

  • Direct PI(3)P modulation: Use PI(3)P-targeted tools like the GFP-Sac1ΔC-FYVE EEA1 chimera mentioned in to specifically alter PI(3)P levels

  • Pathway interference: Systematically inhibit processes downstream of PI(3)P signaling

  • Synthetic phosphoinositide sensors: Deploy sensors that selectively bind different phosphoinositide species

• Genetic interaction analysis:

  • Epistasis testing: Determine whether phenotypes of double mutants match either single mutant

  • Suppressor screening: Identify genes whose mutation suppresses ymr1Δ phenotypes

  • Dosage suppression: Test whether overexpression of potential downstream factors bypasses YMR1 requirement

• Combined genetic and biochemical approaches:

  • Targeted proteomics: Monitor post-translational modifications of potential YMR1 targets

  • Ribosome profiling: Assess translational changes following YMR1 deletion

  • Metabolic flux analysis: Trace metabolic pathways affected by YMR1 deletion

These strategies collectively enable researchers to build a causal model differentiating direct YMR1 functions from secondary consequences of its deletion.

How can research on yeast YMR1 inform therapeutic approaches for human myotubularin-related disorders?

Research on yeast YMR1 provides valuable insights that can guide therapeutic strategies for human myotubularin-related disorders through several translational approaches:

• Mechanistic understanding:

  • Functional conservation: Yeast YMR1 shares core catalytic functions with human myotubularins, particularly MTM1

  • Disease mutation modeling: Introducing human disease-associated mutations into equivalent YMR1 residues helps predict mutation effects

  • Synthetic lethality insights: The lethality of ymr1Δsjl2Δsjl3Δ triple mutants suggests potential genetic interactions relevant to disease severity

• Therapeutic target identification:

  • Compensatory mechanism discovery: Identifying pathways that naturally compensate for YMR1 loss in yeast

  • Genetic suppressor screening: Finding genes that, when deleted or overexpressed, alleviate ymr1Δ phenotypes

  • Chemical suppressor identification: Screening for compounds that rescue ymr1Δ phenotypes

• Validation platforms:

  • Humanized yeast: Developing yeast strains expressing human myotubularin variants for functional testing

  • High-throughput screening: Using engineered yeast to screen compound libraries for disease modifiers

  • Pharmacological response profiling: Testing how disease-associated mutations affect response to candidate therapeutics

• Precision medicine applications:

  • Variant classification: Using yeast as a platform to functionally categorize variants of uncertain significance

  • Therapeutic stratification: Identifying mutation-specific therapeutic approaches

  • Biomarker development: Defining phosphoinositide or other molecular signatures that correlate with disease severity

• Gene therapy considerations:

  • Minimal functional domain mapping: Identifying the smallest functional units for gene therapy approaches

  • Phosphatase activity requirement: Determining whether catalytic activity is essential for all myotubularin functions

  • Overexpression toxicity assessment: Evaluating potential negative consequences of myotubularin overexpression

These approaches leverage the experimental tractability of yeast to accelerate therapeutic development for these challenging genetic disorders.

What methodologies can assess the impact of disease-associated mutations in YMR1 homologs?

To effectively assess the functional impact of disease-associated mutations in YMR1 homologs, researchers can implement the following methodologies:

These methodologies provide a comprehensive framework for assessing the impact of disease-associated mutations and can guide personalized therapeutic strategies.

How can comparing YMR1 structure and function across species enhance understanding of myotubularin evolution?

Comparative analysis of YMR1 across species provides valuable insights into myotubularin evolution and function:

• Evolutionary conservation mapping:

  • Sequence alignment across diverse organisms from single-celled yeast to humans

  • Identification of invariant residues likely critical for core functions

  • Analysis of lineage-specific adaptations that may reflect specialized functions

  • Correlation of evolutionary conservation with three-dimensional structure

• Domain architecture analysis:

  • Comparison of domain organizations across species (Table 1 shows varying numbers of myotubularins across species)

  • Identification of when domain acquisitions or losses occurred during evolution

  • Functional characterization of species-specific domains

  • Assessment of how domain architecture correlates with organism complexity

• Functional complementation experiments:

  • Cross-species complementation testing (can human MTM1 rescue ymr1Δ phenotypes?)

  • Domain-swapping between orthologs to identify functionally equivalent regions

  • Assessment of substrate specificity evolution across diverse species

  • Identification of species-specific interaction partners

• Phosphoinositide signaling network comparison:

  • Mapping phosphoinositide metabolism pathways across model organisms

  • Identifying evolutionary changes in phosphoinositide-dependent cellular processes

  • Comparing synthetic genetic interaction networks between species

  • Assessing how pathway complexity correlates with myotubularin family expansion

• Disease relevance analysis:

  • Correlation between evolutionary conservation and disease-associated mutations

  • Use of simpler organisms to model disease mechanisms

  • Identification of compensatory mechanisms present in lower organisms but lost in humans

  • Development of evolutionary-informed therapeutic strategies

This evolutionary perspective enhances our understanding of myotubularin function and may reveal fundamental insights applicable to human disease mechanisms and treatment approaches.